Stock listing

BRTX Stock Price, News, Filings & Events — Biorestorative Therapies, Inc.

Selected listing: BRTX · NASDAQ · USD · US

This page tracks Biorestorative Therapies, Inc.'s BRTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BRTX:NASDAQ. BRTX:NASDAQ is the stock-level entry point for investors researching Biorestorative Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biorestorative Therapies, Inc. (BRTX) is a public company based in the United States, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately $7.39 million, the company aims to advance its research and product offerings in the healthcare sector. BRTX is committed to improving patient outcomes through its specialized therapeutic solutions.

BRTX:NASDAQUSDUSUpdated September 18, 2026
Biorestorative Therapies, Inc. logo
Ticker
BRTX:NASDAQ
Asset type
Stock
Market cap
$3.7M
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD

Biorestorative Therapies, Inc. BRTX:NASDAQ stock context

This page tracks Biorestorative Therapies, Inc.'s BRTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BRTX:NASDAQ. BRTX:NASDAQ is the stock-level entry point for investors researching Biorestorative Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biorestorative Therapies, Inc. (BRTX) is a public company based in the United States, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately $7.39 million, the company aims to advance its research and product offerings in the healthcare sector. BRTX is committed to improving patient outcomes through its specialized therapeutic solutions.

Latest news from Biorestorative Therapies, Inc.

All Biorestorative Therapies, Inc. news →

Biorestorative Therapies, Inc. earnings calls

Research Biorestorative Therapies, Inc.

Alternate listings